ABSTRACT
BACKGROUND The use of traditional models to predict heart failure (HF) has limitations in preventing HF hospitalizations. Artificial intelligence (AI) and machine learning (ML) in cardiovascular medicine only have limited data published regarding HF populations, with none assessing the favorability of decongestive therapy aquapheresis (AQ). AI and ML can be leveraged to design non-traditional models to identify those who are at high risk of HF readmissions.
OBJECTIVES This study aimed to develop a model for pretreatment identification of risk for 90-day HF events among HF patients who have undergone AQ.
METHODS Using data from the AVOID-HF (Aquapheresis versus Intravenous Diuretics and Hospitalization for Heart Failure) trial, we designed a ML-based predictive model that can be used before initiating AQ to anticipate who will respond well to AQ and who will be at high risk of future HF events.
RESULTS Using ML we identified the top ten predictors for 90-day HF events. Interestingly, the variable for ‘intimate relationships with loved ones’ strongly predicted response to therapy. This ML-model was more successful in predicting the outcome in HF patients who were treated with AQ. In the original AVOID-HF trial, the overall 90-day HF event rate in the AQ arm was 32%. Our proposed predictive model was accurate in anticipating 90-day HF events with better statistical accuracy (area under curve 0.88, sensitivity 80%, specificity 75%, negative predictive value 90%, and positive predictive value 57%).
CONCLUSIONS ML can help identify HF patients who will respond to AQ therapy. Our model can identify super-respondents to AQ therapy and predict 90-day HF events better than currently existing traditional models.
CONDENSED ABSTRACT Utilizing data from the AVOID-HF trial, we designed a ML-predictive model that can be used before initiating AQ to anticipate who will respond well to AQ and who will be at high risk of future HF events. Using ML, we identified the top 10 predictors for 90-day HF events. Our model can identify super-respondents to ultrafiltration therapy and predict 90-day HF events better than currently existing traditional models.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The research received no external funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Not Applicable
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study used data from the AVOID-HF (Aquapheresis versus Intravenous Diuretics and Hospitalization for Heart Failure) trial (all data was de-identified)
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Not Applicable
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Not Applicable
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Not Applicable
Footnotes
↵* Co-first authorship
FUNDING: The research received no external funding.
AUTHOR DISCLOSURES: The authors declare no conflict of interest.
Short Tweet: Using #ArtificialIntelligence we identified the top 10 predictors for 90-day #HeartFailure events. This AI-model was more successful in predicting the outcome in HF patients treated with Aquapheresis. #CardioTwitter #JACCHF
Twitter Handles: @JACCJournals @HFSA @Deya_AlkhatibMD @akbilgicbmi
Data Availability
Any requests for data should be made in writing to the corresponding author, and the data will be provided in accordance with relevant institutional and ethical guidelines.
ABBREVIATIONS AND ACRONYMS
- ADHF
- acute decompensated heart failure
- AI
- artificial intelligence
- AQ
- Aquapheresis
- HF
- heart failure
- IV
- intravenous
- LD
- loop diuretic
- ML
- machine learning
- UF
- ultrafiltration
